JYNNEOS

This brand name is authorized in United States. It is also authorized in Estonia.

Active ingredients

The drug JYNNEOS contains one active pharmaceutical ingredient (API):

1	Smallpox, live attenuated UNII JDS6958QAG - VACCINIA VIRUS
	Smallpox vaccine is indicated for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.
	Read more about Smallpox, live attenuated

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
JYNNEOS Suspension for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BX01		J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BX Other viral vaccines
Discover more medicines within J07BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1887756
US	FDA, National Drug Code	50632-001